Zhengye Biotechnology reported a net loss of RMB22.2 million for H1 2026, improving from RMB25.6 million a year earlier, despite an 18.3% revenue decline to RMB50.9 million. The company increased its gross profit margin to 32.9%, driven by better margins in its other vaccines segment, while cutting operating expenses by 22.2%. Zhengye plans to focus on cost discipline, expand into household animal vaccines, and explore new international markets to drive sustainable growth. This strategic shift aims to strengthen competitiveness and long-term value creation amid challenging market conditions.
Zhengye Biotechnology's financial results for the first half of fiscal year 2026 provide context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 23 rose and 124 fell today. Notable movers include SMMT (Summit Therapeutics Inc) at USD 15.10 with a 1-day change of -9.25% and a typical hold time of 19 days, IBRX (ImmunityBio Inc. Common Stock) at USD 6.06 down 9.15% with a 4-day hold time, and BNGO (BioNano Genomics Inc) at USD 1.00 down 9.09% with a 52-day hold time. Pluang order activity shows mixed sentiment among these stocks.
Super League Enterprise, a company specializing in audience intelligence and media activation for the gaming industry, announced it will release its financial results for the third quarter ending September 30, 2026, on November 16, 2026, after market...
Stantec Inc. reported a 9.4% increase in net revenue to $1.9 billion for Q3 2026, driven by organic and acquisition growth. Adjusted EBITDA rose 16.6% to $377.1 million with a record margin of 20.2%, while adjusted EPS grew 23.5% to $1.89. The compan...
Siemens reported earnings per share of $1.62 and revenue of $26.28 billion, both exceeding analyst expectations. The company saw record orders and double-digit revenue growth in its smart infrastructure and digital industries units, prompting it to r...
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
